Symbol="RETA"
AssetType="Common Stock"
Name="Reata Pharmaceuticals Inc"
Description="Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel therapies for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cell metabolism and inflammation. The company is headquartered in Plano, Texas."
CIK="1358762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="5320 LEGACY DRIVE, PLANO, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="6226022000"
EBITDA="-323340000"
PERatio="None"
PEGRatio="0"
BookValue="-3.482"
DividendPerShare="0"
DividendYield="0"
EPS="-9.73"
RevenuePerShareTTM="0.041"
ProfitMargin="0"
OperatingMarginTTM="-216.73"
ReturnOnAssetsTTM="-0.358"
ReturnOnEquityTTM="-5.19"
RevenueTTM="1497000"
GrossProfitTTM="-167627000"
DilutedEPSTTM="-9.73"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.787"
AnalystTargetPrice="153.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="414.73"
PriceToBookRatio="285.94"
EVToRevenue="316.34"
EVToEBITDA="-3.746"
Beta="1.369"
num_52WeekHigh="167.24"
num_52WeekLow="18.47"
num_50DayMovingAverage="99.66"
num_200DayMovingAverage="68.2"
SharesOutstanding="33036100"
DividendDate="None"
ExDividendDate="None"
symbol="RETA"
open="165.51"
high="166.88"
low="165.08"
price="165.58"
volume="3325962.00"
latest_trading_day="2023-07-31"
previous_close="167.19"
change="-1.61"
change_percent="-0.9630%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Overbought"
value_analysis="Overvalued"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="879147"
Change_recent_avg="0.22"
Delta_recent_avg="4.38"
Variance_recent_avg="2.19"
Change_ratio_recent_avg="0.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="113"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0063.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="962"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_positive_thumbnail_id_2="1166"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
